Rooted in Hawaiʻi. Built for participation.
← Back to HB2224
Read the measure

HB2224

Relating To Medicaid.

Selected version

Amended· Feb 17, 2026

Open the official document ↗

This is a particular imported version. Later drafts may change its provisions, and a recorded vote is not automatically linked to this version.

Choose another version

Readable transcription of the selected official document, not a summary. [Underlined: …] and [Struck through: …] describe recognized source typography; they do not independently establish that wording was legally added or deleted. Layout, tables, and other typography may differ; consult the official document for authoritative wording and formatting. This version is not automatically the version considered in a particular vote.

HOUSE OF REPRESENTATIVES

H.B. NO.

2224

THIRTY-THIRD LEGISLATURE, 2026

H.D. 1

STATE OF HAWAII

A BILL FOR AN ACT

RELATING TO MEDICAID.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:

SECTION 1. The legislature finds that the State's medicaid program, known as med-QUEST, serves some of Hawaii's most vulnerable residents, including low-income families, kupuna, individuals with disabilities, and those living in rural and neighbor island communities. The legislature further finds that decisions regarding pharmaceutical benefit management can significantly impact pharmacy reimbursement, patient access, and overall health care expenditures. Accordingly, it is in the State's best interest to ensure that the department of human services retains the flexibility necessary to evaluate and implement pharmaceutical benefit management structures that best serve medicaid beneficiaries and participating providers.

The legislature further finds that existing limitations on the department's authority constrain the State's ability to modernize medicaid program administration and adapt to evolving health care delivery and pharmaceutical market conditions. These constraints hinder the department's ability to consider emerging models that are being adopted and evaluated at both the federal and state levels.

The purpose of this Act is to restore the department of human services' authority to assess and implement the most effective pharmaceutical benefits management approach for med-QUEST and ensure responsible stewardship of public funds.

SECTION 2. Act 4, Special Session Laws of Hawaii 2005, is amended by amending section 3 to read as follows:

"SECTION 3. [[Struck through: The department of human services shall not take any action to remove pharmaceutical benefits management from managed care plans that provide health care coverage for Hawaii medicaid beneficiaries.]] [Underlined: Repealed.]"[Underlined: ]

SECTION 3. Statutory material to be repealed is bracketed and stricken. New statutory material is underscored.

SECTION 4. This Act shall take effect on July 1, 3000.

Report Title:

Department of Human Services; Medicaid; Pharmaceutical Benefits Management; Managed Care Plans

Description:

Repeals a provision in Act 4, Special Session Laws of Hawaii 2005, that prohibits the Department of Human Services from taking any action to remove pharmaceutical benefits management from managed care plans that provide health care coverage for Hawaii Medicaid beneficiaries. Effective 7/1/3000. (HD1)

The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.

Source: Hawaiʻi State Legislature · Retrieved Nov 8, 2026 · Source document ↗